French AFib Patients' blood thinner patterns scrutinized for bleeding risks
NCT ID NCT05038228
First seen Nov 20, 2025 · Last updated May 16, 2026 · Updated 27 times
Summary
This study reviewed medical records from French health insurance to see how doctors prescribe blood thinners (like apixaban or warfarin) to atrial fibrillation patients who also have a high risk of stomach bleeding. Researchers looked at which treatments were used and whether patients later had serious bleeding or strokes. The goal was to understand real-world treatment patterns and outcomes, not to test a new drug.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ATRIAL FIBRILLATION are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Pfizer Investigator
London, United Kingdom
Conditions
Explore the condition pages connected to this study.